174 related articles for article (PubMed ID: 37296772)
21. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease.
Stevens WW; Staudacher AG; Hulse KE; Carter RG; Winter DR; Abdala-Valencia H; Kato A; Suh L; Norton JE; Huang JH; Peters AT; Grammer LC; Price CPE; Conley DB; Shintani-Smith S; Tan BK; Welch KC; Kern RC; Schleimer RP
J Allergy Clin Immunol; 2021 Feb; 147(2):600-612. PubMed ID: 32371071
[TBL] [Abstract][Full Text] [Related]
22. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
Buchheit KM; Lewis E; Gakpo D; Hacker J; Sohail A; Taliaferro F; Berreondo Giron E; Asare C; Vukovic M; Bensko JC; Dwyer DF; Shalek AK; Ordovas-Montanes J; Laidlaw TM
J Allergy Clin Immunol; 2021 Aug; 148(2):574-584. PubMed ID: 34144111
[TBL] [Abstract][Full Text] [Related]
23. Histopathological and hematological changes in recurrent nasal polyposis.
Brescia G; Alessandrini L; Zanotti C; Parrino D; Tealdo G; Torsello M; Zybine V; Giacomelli L; Barion U; Marioni G
Int Forum Allergy Rhinol; 2019 Jul; 9(7):813-820. PubMed ID: 30786175
[TBL] [Abstract][Full Text] [Related]
24. Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype.
Miglani A; Divekar RD; Azar A; Rank MA; Lal D
Int Forum Allergy Rhinol; 2018 Sep; 8(9):1047-1051. PubMed ID: 29851243
[TBL] [Abstract][Full Text] [Related]
25. Are neutrophil-, eosinophil-, and basophil-to-lymphocyte ratios useful markers for pinpointing patients at higher risk of recurrent sinonasal polyps?
Brescia G; Pedruzzi B; Barion U; Cinetto F; Giacomelli L; Martini A; Marioni G
Am J Otolaryngol; 2016; 37(4):339-45. PubMed ID: 27045767
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis.
Morrissey DK; Bassiouni A; Psaltis AJ; Naidoo Y; Wormald PJ
Int Forum Allergy Rhinol; 2016 Aug; 6(8):820-5. PubMed ID: 26992029
[TBL] [Abstract][Full Text] [Related]
27. Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
Bachert C; Sousa AR; Han JK; Schlosser RJ; Sowerby LJ; Hopkins C; Maspero JF; Smith SG; Kante O; Karidi-Andrioti DE; Mayer B; Chan RH; Yancey SW; Chaker AM
J Allergy Clin Immunol; 2022 May; 149(5):1711-1721.e6. PubMed ID: 35007624
[TBL] [Abstract][Full Text] [Related]
28. Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps.
Steehler AJ; Vuncannon JR; Wise SK; DelGaudio JM
Int Forum Allergy Rhinol; 2021 Nov; 11(11):1549-1556. PubMed ID: 34076353
[TBL] [Abstract][Full Text] [Related]
29. Pre- and postoperative blood neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios in patients with sinonasal polyps: A preliminary investigation.
Brescia G; Barion U; Zanotti C; Parrino D; Marioni G
Allergy Asthma Proc; 2017 Sep; 38(5):64-69. PubMed ID: 28814353
[TBL] [Abstract][Full Text] [Related]
30. Steroids Inhibit Eosinophil Accumulation and Downregulate Hematopoietic Chemotaxic Prostaglandin D
Suzuki N; Ko-Mitamura EP; Inui T; Terada T; Dejima K; Nagata N; Urade Y; Kawata R
Ear Nose Throat J; 2021 Sep; 100(5_suppl):738S-745S. PubMed ID: 32077309
[TBL] [Abstract][Full Text] [Related]
31. Polyps' Extension and Recurrence in Different Endotypes of Chronic Rhinosinusitis: A Series of 449 Consecutive Patients.
Calvanese L; Fabbris C; Brescia G; Di Pasquale Fiasca VM; Deretti A; Finozzi F; Franz L; Frigo AC; Marioni G
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398437
[TBL] [Abstract][Full Text] [Related]
32. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
33. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
[TBL] [Abstract][Full Text] [Related]
34. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
35. Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients.
Choby G; O'Brien EK; Smith A; Barnes J; Hagan J; Stokken JK; Strumpf A; Mattos JL; Payne SC; Divekar R
Laryngoscope; 2021 May; 131(5):961-966. PubMed ID: 33001452
[TBL] [Abstract][Full Text] [Related]
36. [The study of association of chronic rhinosinusitis inflammation subtype with bronchial inflammation phenotype].
Zhang M; Wang JT; Wu DW; Tan LP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):48-52. PubMed ID: 29798210
[No Abstract] [Full Text] [Related]
37. Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease.
Schneider S; Campion NJ; Villazala-Merino S; Liu DT; Bartosik T; Landegger LD; Ahmadi N; Mueller CA; Vyskocil E; Stanek V; Quint T; Bangert C; Eckl-Dorna J
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32231056
[TBL] [Abstract][Full Text] [Related]
38. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?
Klimek L; Dollner R; Pfaar O; Mullol J
Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773
[TBL] [Abstract][Full Text] [Related]
39. Chronic Rhinosinusitis with Nasal Polyps and Asthma.
Laidlaw TM; Mullol J; Woessner KM; Amin N; Mannent LP
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1133-1141. PubMed ID: 33065369
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and differential diagnosis of nasal polyps.
Chaaban MR; Walsh EM; Woodworth BA
Am J Rhinol Allergy; 2013; 27(6):473-8. PubMed ID: 24274222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
